Should burden of disease estimates include cannabis use as a risk factor for psychosis?

PLoS Medicine
L DegenhardtTheo Vos


No abstract listed.


Nov 1, 1991·The Journal of Nervous and Mental Disease·W W EatonG Nestadt
Nov 21, 1990·JAMA : the Journal of the American Medical Association·D A RegierF K Goodwin
Aug 1, 1990·The Journal of Nervous and Mental Disease·A Y Tien, J C Anthony
Jul 1, 1989·The Journal of Nervous and Mental Disease·J G BarbeeC E Kehoe
Apr 9, 1988·British Medical Journal·S AndreassonA Romelsjö
Nov 1, 1987·The Journal of Nervous and Mental Disease·F R Schneier, S G Siris
Jul 1, 1973·Archives of General Psychiatry·D S Bell
Jun 1, 1984·JAMA : the Journal of the American Medical Association·R Doll
Jul 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·J Smith, S Hucker
Jan 1, 1994·The American Journal of Orthopsychiatry·R WarnerH Weinberg
Nov 1, 1996·Drug and Alcohol Dependence·H Thomas
Jul 6, 2000·The Australian and New Zealand Journal of Psychiatry·M Hambrecht, H Häfner
Feb 15, 2001·International Journal of Epidemiology·G Davey Smith, S Ebrahim
Feb 24, 2001·The Australian and New Zealand Journal of Psychiatry·W Hall, L Degenhardt
Apr 12, 2001·Journal of Clinical Epidemiology·G D Smith
Jan 22, 2002·Cyberpsychology & Behavior : the Impact of the Internet, Multimedia and Virtual Reality on Behavior and Society·E B Weiser
Aug 16, 2002·American Journal of Epidemiology·J van OsH Verdoux
Oct 31, 2002·The Australian and New Zealand Journal of Psychiatry·Lisa J PhillipsPatrick D McGorry
Nov 26, 2002·BMJ : British Medical Journal·Louise ArseneaultTerrie E Moffitt
Jan 22, 2003·JAMA : the Journal of the American Medical Association·Michael T LynskeyNicholas G Martin
Jan 23, 2003·Psychological Medicine·D M FergussonN R Swain-Campbell
Jun 25, 2003·Drug and Alcohol Dependence·Louisa DegenhardtMichael Lynskey
Nov 5, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Gavin AndrewsHelen Lapsley
Feb 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Louise ArseneaultRobin M Murray
Jun 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Gavin AndrewsHelen Lapsley
Jun 3, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Deepak Cyril D'SouzaJohn Harrison Krystal
Sep 17, 2004·Addiction·Stanley Zammit, Glyn Lewis
Mar 1, 2005·Addiction·David M FergussonElizabeth M Ridder
Oct 4, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Bob GreenDavid Kavanagh
Oct 6, 2005·Drug and Alcohol Review·W Hall
Jun 6, 2006·European Journal of Public Health·Slavenka JankovicUlrich Laaser
Jul 25, 2006·Environmental Health : a Global Access Science Source·Paolo Vineis, David Kriebel
Sep 30, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Louisa Degenhardt, Wayne Hall
Mar 17, 2007·Schizophrenia Research·Wulf RösslerVladeta Ajdacic Gross
Jul 17, 2007·Schizophrenia Research·Vladeta Ajdacic-GrossWulf Rössler

❮ Previous
Next ❯


Oct 29, 2010·Schizophrenia Bulletin·Alan S Brown, John J McGrath
Nov 28, 2012·L'Encéphale·J VilainA Szöke
Nov 26, 2010·Journal of the American Academy of Child and Adolescent Psychiatry·Michael T LynskeyAndrew C Heath
Apr 13, 2010·The International Journal on Drug Policy·Daniel WerbEvan Wood
Jun 19, 2015·Drug and Alcohol Review·Louisa DegenhardtGeorge Patton
Jul 12, 2014·Journal of Racial and Ethnic Health Disparities·Nicholas SpenceKathryn Graham
Nov 27, 2015·Multivariate Behavioral Research·Wolfgang Wiedermann, Alexander von Eye
Dec 3, 2016·The International Journal on Drug Policy·Wayne Hall
May 21, 2015·The Australian and New Zealand Journal of Psychiatry·John J McGrathJames G Scott
Jun 24, 2017·American Journal of Public Health·Benedikt FischerRobin Room
Oct 27, 2016·BMC Psychology·Karina K KedziorMathew Martin-Iverson
Aug 8, 2019·Early Intervention in Psychiatry·Lilith Abrahamyan EmpsonPhilippe Conus
Nov 26, 2015·Addiction·Sameer ImtiazJürgen Rehm
Aug 24, 2020·Current Opinion in Psychology·Ian Hamilton, Harry Sumnall

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.